A Treatment Algorithm for Moderate to Severe Atopic Dermatitis in Adults

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Cutaneous Medicine and Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1203475417733460PMID 29082775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis

  2017cited by this paper
• Review of Systemic Treatment Options for Adult Atopic Dermatitis

  2017cited by this paper
• Molecular mechanisms in atopic eczema: insights gained from genetic studies

  2017cited by this paper
• Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

  2017cited by this paper
• Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.

  2016cited by this paper
• Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

  2016cited by this paper
• Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres

  2015cited by this paper
• Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

  2014cited by this paper
• Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

  2014cited by this paper
• A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy

  2014cited by this paper
• Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.

  2014cited by this paper
• Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.

  2014cited by this paper
• Willingness to pay and quality of life in patients with atopic dermatitis

  2014cited by this paper
• Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.

  2014cited by this paper
• Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches.

  2014cited by this paper
• Insight into newly discovered innate immune modulation in atopic dermatitis

  2013cited by this paper
• A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

  2013cited by this paper
• Visual analogue scale: evaluation of the instrument for the assessment of pruritus.

  2012cited by this paper
• Health Outcome Measures in Atopic Dermatitis: A Systematic Review of Trends in Disease Severity and Quality-of-Life Instruments 1985–2010

  2011cited by this paper
• Prednisolone vs. ciclosporin for severe adult eczema. An investigator‐initiated double‐blind placebo‐controlled multicentre trial

  2010cited by this paper
• Prevalence of Atopic Dermatitis among Korean Adults Visiting Health Service Center of the Catholic Medical Center in Seoul Metropolitan Area, Korea

  2010cited by this paper
• Outpatient care and medical treatment of children and adults with atopic eczema

  2009cited by this paper
• Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis

  2005cited by this paper
• Hormonal Approach to the Treatment of Acne

  2005cited by this paper
• Hormonal approach to the treatment of acne a Canadian perspective.

  2004cited by this paper
• 10 years experience of the Dermatology Life Quality Index (DLQI).

  2004cited by this paper
• Outcome measures of disease severity in atopic eczema.

  2000cited by this paper
• Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use

  1994cited by this paper

• Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis

  2024cites this paper
• [Algoritmo de tratamiento de la dermatitis atópica en Perú. Consenso de expertos].

  2023cites this paper
• Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II

  2022cites this paper
• Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.

  2022cites this paper
• National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)

  2022cites this paper
• Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis

  2022cites this paper
• Inadequate response and treatment patterns in adults diagnosed with atopic dermatitis and treated with topical therapy

  2021cites this paper
• Patient Journey in Atopic Dermatitis: The Real-World Scenario

  2021cites this paper
• Unmet needs in atopic dermatitis management: an expert consensus

  2021cites this paper
• Current and emerging biologic and small molecule therapies for atopic dermatitis

  2019cites this paper
• Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative

  2019cites this paper
• Atopic dermatitis in adults: An Australian management consensus

  2019cites this paper
• Translating Evidence to Practice: From Clinical Research to Real-World Experience

  2019cites this paper
• Cancérologie cutanée et dermatite atopique

  2019cites this paper
• Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis

  2018cites this paper
• Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy

  2018cites this paper
• Consensus statement CONSENSUS STATEMENT OF THE MANAGEMENT OF SEVERE, DIFFICULT-TO-TREAT ATOPIC DERMATITIS IN ADULTS AND ADOLESCENTS IN SOUTH AFRICA AND THE ROLE OF BIOLOGICS

  year unknowncites this paper